STOCK TITAN

Veracyte Named a Greater Bay Area Top Workplace by the San Francisco Chronicle

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Very Positive)
Tags

Veracyte (Nasdaq: VCYT), a leading cancer diagnostics company, has been named a Bay Area Top Workplace by the San Francisco Chronicle for the 11th consecutive year. This recognition is based solely on employee feedback gathered through a confidential survey administered by Energage, measuring various aspects of employee experience.

The survey assesses themes such as employee respect, support, growth opportunities, and empowerment. Marc Stapley, Veracyte's CEO, expressed honor in receiving this award, emphasizing the company's commitment to its employees and its vision of transforming cancer care globally. Veracyte believes that its employees are important in guiding clinicians and focusing on advancing cancer care.

Veracyte (Nasdaq: VCYT), un'azienda leader nel campo della diagnostica oncologica, è stata nominata Top Workplace della Bay Area dal San Francisco Chronicle per l'11° anno consecutivo. Questo riconoscimento si basa esclusivamente sul feedback dei dipendenti, raccolto tramite un sondaggio confidenziale amministrato da Energage, che misura vari aspetti dell'esperienza dei dipendenti.

Il sondaggio valuta temi come il rispetto dei dipendenti, il supporto, le opportunità di crescita e l'empowerment. Marc Stapley, CEO di Veracyte, ha espresso onore nel ricevere questo premio, sottolineando l'impegno dell'azienda verso i propri dipendenti e la sua visione di trasformare la cura del cancro a livello globale. Veracyte crede che i suoi dipendenti siano fondamentali nell'orientare i clinici e nel concentrarsi sull'avanzamento della cura oncologica.

Veracyte (Nasdaq: VCYT), una empresa líder en diagnósticos del cáncer, ha sido nombrada Mejor Lugar para Trabajar en el Área de la Bahía por el San Francisco Chronicle por undécimo año consecutivo. Este reconocimiento se basa únicamente en el feedback de los empleados recopilado a través de una encuesta confidencial administrada por Energage, que mide diversos aspectos de la experiencia laboral.

La encuesta evalúa temas como el respeto hacia los empleados, el apoyo, las oportunidades de crecimiento y el empoderamiento. Marc Stapley, CEO de Veracyte, expresó su honor al recibir este premio, enfatizando el compromiso de la empresa con sus empleados y su visión de transformar la atención del cáncer a nivel global. Veracyte cree que sus empleados son importantes para guiar a los clínicos y enfocarse en avanzar en la atención del cáncer.

Veracyte (Nasdaq: VCYT), 암 진단 분야의 선두주자인 기업이 베이 에어리어 최고의 직장으로 11년 연속 샌프란시스코 크로니클에 의해 선정되었습니다. 이 인시는 오로지 직원들의 피드백에 기반하며, Energage가 관리하는 비밀 설문조사를 통해 수집된 다양한 직원 경험을 측정합니다.

이 설문조사는 직원 존중, 지원, 성장 기회 및 권한 부여와 같은 주제를 평가합니다. Marc Stapley Veracyte의 CEO는 이 상을 수상하게 되어 영광이라고 표현하며, 회사의 직원에 대한 헌신과 전 세계적으로 암 치료를 혁신하겠다는 비전을 강조했습니다. Veracyte는 직원들이 임상의들을 안내하고 암 치료 진전을 위해 집중하는 데 중요하다고 믿습니다.

Veracyte (Nasdaq: VCYT), une entreprise leader dans le diagnostic du cancer, a été désignée meilleur lieu de travail de la Bay Area par le San Francisco Chronicle pour la 11e année consécutive. Cette reconnaissance est uniquement basée sur le retour des employés recueilli à travers une enquête confidentielle administrée par Energage, mesurant divers aspects de l'expérience des employés.

L'enquête évalue des thèmes tels que le respect des employés, le soutien, les opportunités de croissance et l'autonomisation. Marc Stapley, PDG de Veracyte, a exprimé son honneur de recevoir ce prix, en soulignant l'engagement de l'entreprise envers ses employés et sa vision de transformer les soins du cancer à l'échelle mondiale. Veracyte considère que ses employés sont essentiels pour guider les cliniciens et se concentrer sur l'avancement des soins du cancer.

Veracyte (Nasdaq: VCYT), ein führendes Unternehmen in der Krebsdiagnostik, wurde zum Top-Arbeitsplatz der Bay Area vom San Francisco Chronicle für das 11. Jahr in Folge ernannt. Diese Auszeichnung basiert ausschließlich auf dem Feedback der Mitarbeiter, das durch eine vertrauliche Umfrage von Energage gesammelt wurde und verschiedene Aspekte der Mitarbeitererfahrung misst.

Die Umfrage bewertet Themen wie den Respekt für Mitarbeiter, Unterstützung, Wachstumschancen und Ermächtigung. Marc Stapley, CEO von Veracyte, äußerte seine Ehre über den Erhalt dieser Auszeichnung und betonte das Engagement des Unternehmens für seine Mitarbeiter und die Vision, die Krebsbehandlung weltweit zu transformieren. Veracyte ist der Überzeugung, dass seine Mitarbeiter entscheidend sind, um Kliniker zu unterstützen und sich auf die Verbesserung der Krebsversorgung zu konzentrieren.

Positive
  • None.
Negative
  • None.

Award marks company’s 11th consecutive year of receiving this honor

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that it has been named a Bay Area Top Workplace by the San Francisco Chronicle. The award marks the 11th consecutive year that Veracyte has received this honor.

The Bay Area Top Workplace award winners are determined based solely on employee feedback gathered by Energage, an employee engagement technology partner. The firm administers a confidential survey that measures employee experience and its component themes, including the degree to which employees feel respected and supported, enabled to grow and empowered to execute, among others.

“We are deeply honored to be recognized as a Top Workplace, which underscores our commitment to our employees and to our vision of transforming cancer care for patients all over the world,” said Marc Stapley, Veracyte’s chief executive officer. “At Veracyte we believe that our employees are our greatest asset and that each plays a key role in our work to guide clinicians to the right next steps for their patients, while we collectively focus on building what’s next in cancer care.”

About Veracyte

Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our Veracyte Diagnostics Platform delivers high-performing cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine, which ultimately drives durable reimbursement and guideline inclusion for our tests, along with new insights to support continued innovation and pipeline development. For more information, please visit www.veracyte.com and follow the company on X (formerly Twitter) at @veracyte.

Investors:

Shayla Gorman

investors@veracyte.com

619-393-1545

Media:

Tracy Morris

media@veracyte.com

650-380-4413

Source: Veracyte, Inc.

FAQ

How many consecutive years has Veracyte (VCYT) been named a Bay Area Top Workplace?

Veracyte (VCYT) has been named a Bay Area Top Workplace for 11 consecutive years.

Who determines the Bay Area Top Workplace award winners for Veracyte (VCYT)?

The Bay Area Top Workplace award winners are determined solely based on employee feedback gathered by Energage, an employee engagement technology partner.

What does the employee survey for Veracyte (VCYT) measure?

The employee survey measures various aspects of employee experience, including respect, support, growth opportunities, and empowerment.

What is Veracyte's (VCYT) vision according to the press release?

Veracyte's vision is to transform cancer care for patients all over the world.

Veracyte, Inc.

NASDAQ:VCYT

VCYT Rankings

VCYT Latest News

VCYT Stock Data

3.42B
76.86M
0.77%
104.86%
3.71%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
SOUTH SAN FRANCISCO